© 2019 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#ASCO 2018
Click Here for More Conferences
3D rendering of the breast
Breast Cancer Tumor Test Lets Many Women Avoid Chemotherapy
Cancer Basics
The U.N. General Assembly Hall during the High-level Meeting on HIV/AIDS.

Conferences

Keytruda Plus Chemotherapy Approved for Metastatic Squamous Lung Cancer

Immunotherapy combination reduced the risk of death by 36 percent compared with chemotherapy alone.

Less Is More for Early Breast Cancer

Genetic test can help guide decisions about treatment after surgery.
Multiple myeloma cells

New CAR-T for Multiple Myeloma

Half of those treated with the experimental immunotherapy bb2121 no longer had detectable cancer.
Gilber Loopes, MD

Combos for Lung Cancer

Immunotherapy worked better than chemotherapy as first-line treatment for people with a favorable biomarker.
Cancers with RET fusions (Drilon et al, ASCO 2018, abstract 102)

Arresting RET

New drug targets RET mutations in multiple cancer types.

Integrative Not Alternative

Yoga, meditation, acupuncture and more can be safely used to relieve side effects of standard treatment.

Meet Your Match

Using molecular tests to select the most appropriate treatment leads to better outcomes.

Get Fit

Fitness trackers predict how cancer patients will respond to treatment.
José Baselga, MD, PhD

PI3K Inhibitors Slow Progression of Advanced Breast Cancer

Taselisib and alpelisib improve progression-free survival, but side effects are a concern.
Arnaud Mejean, MD

Many Advanced Kidney Cancer Patients Don’t Need Surgery

Those who received targeted therapy did equally well without kidney removal.

Hot topics

#Immunotherapy
#Chemotherapy

Tecentriq Plus Chemotherapy Reduces Progression of Advanced Lung Cancer

Immunotherapy combo leads to longer progression-free survival.

Cyramza Extends Liver Cancer Survival

Twice as many patients were alive 18 months after starting treatment.
Gilberto Lopes at ASCO 2018

Keytruda Beats Chemotherapy for Most Common Type of Advanced Lung Cancer

Immunotherapy worked better than chemotherapy as first-line treatment for people with a favorable biomarker.

Nelarabine Improves Survival for Some Young People With Leukemia

“These are the best outcomes reported to date in a Children’s Oncology Group trial for children with this cancer,” said the lead author.
Very high magnification micrograph of Merkel cell carcinoma (MCC). H&E stain. MCCs are aggressive neuroendocrine tumour of the skin. They can be considered a small round cell tumor.

Immunotherapy Benefits Patients With Advanced Merkel Cell Carcinoma

‘Incredibly big change’ in treatment of deadly skin cancer, new data show
Advertisement
Treatment News
Newsfeed
Features
Opinions